LAKE ZURICH, Illinois, October 20 /PRNewswire/ --

Fenwal, Inc. today announced a new partnership with Data Innovations,
Inc. to develop, distribute and license a data capture and reporting system
for Fenwal's automated blood component collection systems. This collaboration
will allow blood centers to export data from Fenwal's automated blood
collection devices into The Instrument Manager(TM) system that will generate
standard and customized reports analyzing critical donor and procedural
information.

A data capture and reporting system will help blood centers drive
operational efficiencies by eliminating the need to manually capture this
information from Fenwal's automated collection devices. It will also allow
blood centers to more easily identify and track donor and procedure trends,
further improving their collection management efforts. Fenwal will begin
offering a data capture and reporting system with Data Innovations in 2008
for its ALYX, AMICUS and Autophersis-C automated collection devices in the
United States, and will then expand this offering to Europe and other
regions.

"As an independent company entirely focused on the transfusion medicine
community, Fenwal is committed to investing in research and development
programs that will bring the best portfolio of products and solutions to our
customers," said Ron K. Labrum, Fenwal President and CEO. "When our needs
require that we go outside the company for specific expertise, Fenwal will
partner with other world-class leaders, such as Data Innovations, to help us
meet and exceed our customers' needs and expectations."

Fenwal selected Data Innovations for this collaboration due to the
company's unique middleware expertise, which is software that both connects
separate instruments and systems and allows them to communicate with each
other and helps the lab manage that data to streamline workflows. Future
integrated data management solutions Fenwal will introduce with Data
Innovations include: interfaces to donor information/management systems,
remote services diagnostics and more.

"We have been looking to expand and add efficiencies in the blood and
plasma center value chain," said Gregory Vail, President of Data Innovations.
"Fenwal is a respected, global leader in the transfusion medicine community
and their broad product offering, commitment to innovation, and strong
customer relationships made them a clear choice to partner with in bringing
data management solutions to this industry."

Fenwal is a leading, global healthcare company focused on the
development, manufacture and marketing of products and services for the
transfusion medicine industry. The company provides a comprehensive portfolio
of products and services for manual and automated blood collection,
processing and storage. For more information, please visit
http://www.fenwalinc.com.

Data Innovations is the world's largest clinical laboratory middleware
company offering comprehensive solutions encompassing pre-analytical,
analytical, and post analytical process improvement. For more information,
please visit http://www.datainnovations.com.

Web site: http://www.fenwalinc.com
              http://www.datainnovations.com